* Applied Molecular Transport Inc. AMTI.OQ AMTI.O is
expected
to show no change in quarterly revenue when it reports results
*
* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 50 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Applied
Molecular
Transport Inc. is $1, above its last closing price of $0.14.
This summary was machine generated November 3 at 12:46 GMT. All
figures in US dollars unless otherwise stated